Gurugram (Haryana) [India], March 11: LG Electronics India, in collaboration with Saksham Bharti Foundation, successfully organized a four-day blood donation camp from March 7th to March 10th in Gurugram. This impactful initiative witnessed overwhelming participation, with nearly 2,000 donor
The NTR Trust recently hosted a spectacular musical night, "Euphoria," in Vijayawada, Andhra Pradesh, to raise awareness and support for thalassemia patients.
Encouraged by the Law Ministry's initiative to modernize India's legal and regulatory framework, Deepak Chopra, Mentor of the Thalassemia Patients Advocacy Group (TPAG), and Anubha Taneja-Mukherjee, Member Secretary of TPAG, met with Union Minister for Law and Justice Arjun Ram Meghwal and s
In a talk with ANI, Union Heath Secretary Apurva Chandra stated, "Timely detection and prevention are the most effective strategies to tackle thalassemia."
Mumbai (Maharashtra) [India], April 13: On the 13th and 14th of April, 2024, Mumbai is witnessing a unique and inspiring endeavor by ImPaCCT Foundation, Tata Memorial Centre along with Duhita Foundation (NGO). The event is set to be a celebration of resilience and hope, featuring 250 partici
The National Thalassemia Welfare Society has written a letter to Delhi's Lieutenant Governor Vinai Kumar Saxena over what it termed acute shortage of necessary kits for essential test for blood transfusion in thalassemia patients in three major hospitals of Delhi government.
Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.
According to the primary researcher, a single treatment of a breakthrough gene-editing therapy has altered the life of a group of patients suffering from a hereditary illness.
In a humanitarian gesture, Odisha Governor Raghubar Das provided financial assistance amounting to Rs 1 lakh for the treatment of an ailing boy during his visit to Ganjam district on Thursday.
After rigorous testing on safety, quality and effectiveness Britain's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a world-first gene therapy, that will work to cure sickle-cell disease as well as B-thalassemia.